(Q37559623)

21 August 2017

1 reference

title

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine (English)

1 reference

pneumococcal conjugate vaccine

21 August 2017

0 references

1 reference

Ener Cagri Dinleyici

1

1 reference

PubMed ID

19627181

21 August 2017

Zeynel Abidin Yargic

series ordinal

2

1 reference

21 August 2017

1 August 2009

1 reference

Expert Review of Vaccines

21 August 2017

1 reference

21 August 2017

8

1 reference

21 August 2017

977-986

1 reference

21 August 2017

8

1 reference

Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.

21 August 2017

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

21 January 2018

1 reference

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

21 January 2018

1 reference

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

21 January 2018

1 reference

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada

21 January 2018

1 reference

Epidemiological differences among pneumococcal serotypes

21 January 2018

1 reference

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

Impact of conjugate pneumococcal vaccines on antibiotic resistance

21 January 2018

1 reference

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines

21 January 2018

1 reference

An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics

21 January 2018

1 reference

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

21 January 2018

1 reference

Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.

21 January 2018

1 reference

Invasive pneumococcal infections among hospitalized children in Bamako, Mali

21 January 2018

1 reference

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era.

21 January 2018

1 reference

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease

21 January 2018

1 reference

Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

21 January 2018

1 reference

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

21 January 2018

1 reference

Pediatric parapneumonic empyema, Spain.

21 January 2018

1 reference

Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media.

21 January 2018

1 reference

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

21 January 2018

1 reference

Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome

21 January 2018

1 reference

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

21 January 2018

1 reference

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem

21 January 2018

1 reference

Streptococcus pneumoniae serotype 19A in children, South Korea

21 January 2018

1 reference

Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007.

21 January 2018

1 reference

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

21 January 2018

1 reference

Temporal and spatial distribution of clonal complexes of Streptococcus pneumoniae isolates resistant to multiple classes of antibiotics in Belgium, 1997 to 2004

21 January 2018

1 reference

Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children

21 January 2018

1 reference

Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population

21 January 2018

1 reference

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States

21 January 2018

1 reference

The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae

21 January 2018

1 reference

Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era

21 January 2018

1 reference

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

21 January 2018

1 reference

Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.68

1 reference

21 August 2017

1 reference

PubMed ID

19627181